Xingang Qin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xingang Qin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Hong Chen
Department of Anesthesiology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, China
2 shared publicationsJianbo He
Department of Anesthesiology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, China
2 shared publicationsKaiming Duan
Department of Anesthesiology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, China
1 shared publicationSikandaier Wushouer
Department of Anesthesiology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, China
1 shared publicationXiaoli Cai
Department of Anesthesiology, The Fifth Affiliated Hospital of Xinjiang Medical University, 830011 Urumqi, Xinjiang, China
1 shared publicationXiaowei Wang
Department of Anesthesiology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, China
1 shared publication
Latest Publications
- Open Access
- 17 July 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1542327
Gene signatures associated with exosomes as diagnostic markers of postpartum depression and their role in immune infiltration
Background: Postpartum depression (PPD) is a significant mental health challenge for new mothers, with diverse and unclear causes. Exosomes significantly contribute to the pathogenesis, identification, treatment outcome determination, and intervention of PPD. However, the functions of exosome-related genes (ERGs) in PPD remain to be fully elucidated. This study examines the potential impact of ERGs on PPD and develops a set of diagnostic tools based on them.Methods: We acquired and prepared several gene expression datasets from the Gene Expression Omnibus (GEO). Our analysis focused on genes that closely interact with the extracellular matrix. Using advanced techniques, including the limma package, we identified differential expression and conducted enrichment analyses of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Furthermore, we employed logistic regression, random forest (RF) classifiers, and least absolute shrinkage and selection operator (LASSO) regression to screen critical genes.Results: We identified 44 exosome-related differentially expressed genes (ERDEGs) that play key roles in synaptic signal transmission, hormone fluctuations, and inflammatory responses. Ten genes, including TPP2, AKR1B1, CD59, PARK7, PLXNB2, HLA-B, FAH, NDST1, SCARB1, and HNRNPA2B1, were established using logistic regression analysis, RF method, and LASSO regression. In these two sets of data, the manifestations of PARK7 and HNRNPA2B1 differed. The analysis showed that the significant enrichment of gene sets was strongly associated with high-risk scores, particularly in the metabolic (phospholipid metabolism) and neural (mitochondrial translation) pathways. Gene set variation analysis (GSVA) revealed four prominent pathways: MYC targets V2, pancreatic beta cells, unfolded protein response, and oxidative phosphorylation. Single-sample gene set enrichment analysis (GSEA) showed that immune cells demonstrated different degrees of infiltration among at-risk and low-probability risk subsets of immature B cells, regulatory T cells), and T follicular helper cells.Conclusions: ERDEGs significantly contribute to PPD occurrence. Our diagnostic model demonstrated high accuracy and potential for use in medical practice. Future research with larger samples is warranted to validate these conclusions and identify effective targets that may affect these pathways during treatment to improve the therapeutic effect.
- 17 July 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1542327
Open AccessGene signatures associated with exosomes as diagnostic markers of postpartum depression and their role in immune infiltration
Background: Postpartum depression (PPD) is a significant mental health challenge for new mothers, with diverse and unclear causes. Exosomes significantly contribute to the pathogenesis, identification, treatment outcome determination, and intervention of PPD. However, the functions of exosome-related genes (ERGs) in PPD remain to be fully elucidated. This study examines the potential impact of ERGs on PPD and develops a set of diagnostic tools based on them.Methods: We acquired and prepared several gene expression datasets from the Gene Expression Omnibus (GEO). Our analysis focused on genes that closely interact with the extracellular matrix. Using advanced techniques, including the limma package, we identified differential expression and conducted enrichment analyses of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Furthermore, we employed logistic regression, random forest (RF) classifiers, and least absolute shrinkage and selection operator (LASSO) regression to screen critical genes.Results: We identified 44 exosome-related differentially expressed genes (ERDEGs) that play key roles in synaptic signal transmission, hormone fluctuations, and inflammatory responses. Ten genes, including TPP2, AKR1B1, CD59, PARK7, PLXNB2, HLA-B, FAH, NDST1, SCARB1, and HNRNPA2B1, were established using logistic regression analysis, RF method, and LASSO regression. In these two sets of data, the manifestations of PARK7 and HNRNPA2B1 differed. The analysis showed that the significant enrichment of gene sets was strongly associated with high-risk scores, particularly in the metabolic (phospholipid metabolism) and neural (mitochondrial translation) pathways. Gene set variation analysis (GSVA) revealed four prominent pathways: MYC targets V2, pancreatic beta cells, unfolded protein response, and oxidative phosphorylation. Single-sample gene set enrichment analysis (GSEA) showed that immune cells demonstrated different degrees of infiltration among at-risk and low-probability risk subsets of immature B cells, regulatory T cells), and T follicular helper cells.Conclusions: ERDEGs significantly contribute to PPD occurrence. Our diagnostic model demonstrated high accuracy and potential for use in medical practice. Future research with larger samples is warranted to validate these conclusions and identify effective targets that may affect these pathways during treatment to improve the therapeutic effect.
- Open Access
- 5 August 2024
- Published by Juan José López-Ibor Foundation in Actas Españolas de Psiquiatría
- Vol. 52 (4) , 484-494
Exploring the Potential Role of Dexmedetomidine in Reducing Postoperative Cognitive Dysfunction in Elderly Hip Fracture Patients
Background: Hip fractures are prevalent in the elderly; however, Postoperative Cognitive Dysfunction (POCD) is a possible complication of hip fracture surgery in elderly patients. This study examines the influence and the underlying mechanism of dexmedetomidine on POCD in elderly patients following hip fracture surgery. Methods: The retrospective study involved elderly patients with hip fracture who were treated at the Fifth Affiliated Hospital of Xinjiang Medical University from October 2021 to August 2022. During the surgery procedures, dexmedetomidine was administrated and the peripheral blood samples were collected from the patients. Inflammatory factors were measured using Enzyme-linked immunosorbent assay (ELISA), while pyroptosis-related proteins were detected through quantitative reverse transcription PCR (RT-qPCR) and western blot. Additionally, the levels of CD4+T and CD8+T cells were assessed using flow cytometry. An aged rats hip fracture model was established to further investigate the impact of dexmedetomidine on postoperative mobility, cognition function, pyroptosis and immune cells in rats. Results: Postoperative cognitive function in patients did not show significant alteration when compared with pre-operation levels (p > 0.05). There were notable reduction in the levels of interleukin-18 (IL-18), Caspase-3, Gasdermin-D (GSDMD) and NLR Family Pyrin Domain Containing 3 (NLRP3) (p < 0.001), accompanied by an increase in the proportion of CD4+T cells and an decrease in CD8+T cells after operation (p < 0.01). In aged rats, postoperative exploratory activities increased compared to their preoperative state. Compared with preoperative levels, the levels of interleukin-1β (IL-1β), IL-18, Caspase-3, GSDMD, and NLRP3 were significantly decreased (p < 0.001), the proportion of CD4+T cells was increased, and the proportion of CD8+T cells was decreased postoperatively (p < 0.01). Conclusions: Although there was no significant alteration in postoperative cognitive function in patients, dexmedetomidine may still play a role in mitigating POCD potentially due to its effects on reducing immune inflammation and pyroptosis markers. Further research is needed to fully understand the underlying mechanisms and its clinical implications.
- 5 August 2024
- Published by Juan José López-Ibor Foundation in Actas Españolas de Psiquiatría
- Vol. 52 (4) , 484-494
Open AccessExploring the Potential Role of Dexmedetomidine in Reducing Postoperative Cognitive Dysfunction in Elderly Hip Fracture Patients
Background: Hip fractures are prevalent in the elderly; however, Postoperative Cognitive Dysfunction (POCD) is a possible complication of hip fracture surgery in elderly patients. This study examines the influence and the underlying mechanism of dexmedetomidine on POCD in elderly patients following hip fracture surgery. Methods: The retrospective study involved elderly patients with hip fracture who were treated at the Fifth Affiliated Hospital of Xinjiang Medical University from October 2021 to August 2022. During the surgery procedures, dexmedetomidine was administrated and the peripheral blood samples were collected from the patients. Inflammatory factors were measured using Enzyme-linked immunosorbent assay (ELISA), while pyroptosis-related proteins were detected through quantitative reverse transcription PCR (RT-qPCR) and western blot. Additionally, the levels of CD4+T and CD8+T cells were assessed using flow cytometry. An aged rats hip fracture model was established to further investigate the impact of dexmedetomidine on postoperative mobility, cognition function, pyroptosis and immune cells in rats. Results: Postoperative cognitive function in patients did not show significant alteration when compared with pre-operation levels (p > 0.05). There were notable reduction in the levels of interleukin-18 (IL-18), Caspase-3, Gasdermin-D (GSDMD) and NLR Family Pyrin Domain Containing 3 (NLRP3) (p < 0.001), accompanied by an increase in the proportion of CD4+T cells and an decrease in CD8+T cells after operation (p < 0.01). In aged rats, postoperative exploratory activities increased compared to their preoperative state. Compared with preoperative levels, the levels of interleukin-1β (IL-1β), IL-18, Caspase-3, GSDMD, and NLRP3 were significantly decreased (p < 0.001), the proportion of CD4+T cells was increased, and the proportion of CD8+T cells was decreased postoperatively (p < 0.01). Conclusions: Although there was no significant alteration in postoperative cognitive function in patients, dexmedetomidine may still play a role in mitigating POCD potentially due to its effects on reducing immune inflammation and pyroptosis markers. Further research is needed to fully understand the underlying mechanisms and its clinical implications.